Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 14, 2026Oct 15 8:44 PMSoleil BoughtonChief Legal Officer
Sale
3,461$29.06$100.6K297,348(D)

View →

Oct 14, 2026Oct 14 1:44 PMBoughton Soleil
Proposed Sale
3,461$29.06$100.6K—

View →

Oct 1, 2026Oct 2 8:32 PMOluyemi OkupeChief Financial Officer
Sale
2,000$29.70$59.4K234,527(D)

View →

Sep 30, 2026Oct 2 8:31 PMSoleil BoughtonChief Legal Officer
Sale
3,461$29.17$101.0K300,809(D)

View →

Oct 1, 2026Oct 1 4:05 PMOkupe Oluyemi
Proposed Sale
2,000$29.70$59.4K—

View →

Sep 30, 2026Sep 30 2:31 PMBoughton Soleil
Proposed Sale
3,461$29.17$101.0K—

View →

Sep 22, 2026Sep 23 8:17 PMOluyemi OkupeChief Financial Officer
Sale
29,277$29.95$876.8K236,527(D)

View →

Sep 22, 2026Sep 22 4:12 PMOkupe Oluyemi
Proposed Sale
29,277$29.95$876.8K—

View →

Sep 17, 2026Sep 18 8:17 PMOluyemi OkupeChief Financial Officer
Sale
12,313$28.82$354.9K251,804(D)

View →

Sep 16, 2026Sep 17 8:17 PMSoleil BoughtonChief Legal Officer
Sale
6,236$27.86$173.7K304,270(D)

View →

Sep 15, 2026Sep 17 8:17 PMMichael ChiChief Operating Officer
Sale
14,027$28.39$398.2K456,660(D)

View →

Sep 15, 2026Sep 17 8:17 PMMohamed ElshenawyCTO
Sale
7,954$28.39$225.8K185,556(D)

View →

Sep 17, 2026Sep 17 7:55 PMOkupe Oluyemi
Proposed Sale
12,313$28.82$354.9K—

View →

Sep 16, 2026Sep 16 2:05 PMBoughton Soleil
Proposed Sale
6,236$27.86$173.7K—

View →

Sep 15, 2026Sep 15 2:22 PMElshenawy Mohamed
Proposed Sale
7,954$28.39$225.8K—

View →

Sep 15, 2026Sep 15 2:14 PMChi Michael
Proposed Sale
14,027$28.39$398.2K—

View →

Sep 2, 2026Sep 3 8:31 PMSoleil BoughtonChief Legal Officer
Sale
3,458$28.33$98.0K310,506(D)

View →

Sep 2, 2026Sep 2 4:24 PMBoughton Soleil
Proposed Sale
3,458$28.33$98.0K—

View →

Aug 18, 2026Aug 20 8:31 PMDeborah M. AutorDirector, Chief Policy Officer
Sale
16,773$27.85$467.1K48,961(D)

View →

Aug 19, 2026Aug 20 8:30 PMOluyemi OkupeChief Financial Officer
Sale
4,938$29.99$148.1K264,117(D)

View →

Page 1 of 11

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,987—16,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369—229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,421—74,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200—137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,076—62,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711—526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489—150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111—188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844—413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978—300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 4 of 4